Search
for
Sort by
Research 421–450 of 1000+
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- The genetics of androgenetic alopecia
- The effect of spironolactone on genital skin 5α-reductase activity
- Androgens Affect the Activity of Human Sebocytes in Culture in a Manner Dependent on the Localization of the Sebaceous Glands and Their Effect Is Antagonized by Spironolactone
- Male pattern baldness: current treatments, future prospects
- Use of Finasteride in the Treatment of Men With Androgenetic Alopecia (Male Pattern Hair Loss)
- The use of liposomes in the topical application of steroids
- Formulation and optimization of transfersome containing minoxidil and caffeine
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- The Basic Science of Hair Biology
- Novel agents for the treatment of alopecia
- Bone density is normal in male rats treated with finasteride.
- The Androgenic Alopecia Protective Effects of Forsythiaside-A and the Molecular Regulation in a Mouse Model
- Inhibitory activities of some traditional Chinese herbs against testosterone 5α-reductase and effects of Cacumen platycladi on hair re-growth in testosterone-treated mice
- Testosterone Reduces Knee Passive Range of Motion and Expression of Relaxin Receptor Isoforms via 5α-Dihydrotestosterone and Androgen Receptor Binding
- Comparison of clinical trials with finasteride and dutasteride.
- The endocrinology of baldness
- Mechanism of Salutary Effects of Finasteride on Post-traumatic Immune/Inflammatory Response
- High circulating oestrone and low testosterone correlate with adverse clinical outcomes in men with advanced liver disease
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Effects of topical application of EGCG on testosterone-induced hair loss in a mouse model
- Testosterone Prevents Cutaneous Ischemia and Necrosis in Males Through Complementary Estrogenic and Androgenic Actions
- Establishment of type II 5α-reductase over-expressing cell line as an inhibitor screening model
- Lack of effect of topical finasteride suggests an endocrine role for dihydrotestosterone
- Predominant expression of 5 alpha-reductase type 1 in pubic skin from normal subjects and hirsute patients.
- Biomarker-based methods for determining noncompliance in a prevention trial
- Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5α-reductase
- Docking and Molecular Dynamics Identify Leads against 5 Alpha Reductase 2 for Benign Prostate Hyperplasia Treatment
- A herbal formula, comprising Panax ginseng and bee-pollen, inhibits development of testosterone-induced benign prostatic hyperplasia in male Wistar rats
- Transcriptomic profiling in Silurana tropicalis testes exposed to finasteride